OTCPK:EOSG.F

Stock Analysis Report

Executive Summary

EOS imaging SA designs, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications.

Snowflake

Fundamentals

Adequate balance sheet and overvalued.

Risks

  • EOS imaging is covered by less than 3 analysts.

Similar Companies

Share Price & News

How has EOS imaging's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:EOSG.F

-1.2%

US Medical Equipment

1.2%

US Market


1 Year Return

-73.8%

OTCPK:EOSG.F

8.7%

US Medical Equipment

1.7%

US Market

EOSG.F underperformed the Medical Equipment industry which returned 8.7% over the past year.

EOSG.F underperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

EOSG.FIndustryMarket
7 Day0%-1.2%1.2%
30 Day0%1.4%4.9%
90 Dayn/a4.8%3.7%
1 Year-73.8%-73.8%9.6%8.7%3.9%1.7%
3 Yearn/a70.8%65.5%47.2%37.7%
5 Yearn/a130.4%104.1%60.0%42.4%

Price Volatility Vs. Market

How volatile is EOS imaging's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is EOS imaging undervalued based on future cash flows and its price relative to the stock market?

1.19x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for EOS imaging to establish if it is available at moderate discount.

Unable to calculate intrinsic value for EOS imaging to establish if it is available at substantial discount.


Price Based on Earnings

EOS imaging is loss making, we can't compare its value to the US Medical Equipment industry average.

EOS imaging is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for EOS imaging, we can't assess if its growth is good value.


Price Based on Value of Assets

EOS imaging is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is EOS imaging expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

39.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

EOS imaging's revenue is expected to grow by 10.7% yearly, however this is not considered high growth (20% yearly).

EOS imaging is not considered high growth as it is expected to be loss making for the next 1-3 years.

EOS imaging's revenue growth is expected to exceed the United States of America market average.

Unable to compare EOS imaging's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.

Unable to compare EOS imaging's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if EOS imaging will efficiently use shareholders’ funds in the future (Return on Equity greater than 20%) as it is not expected to be profitable.


Next Steps

Past Performance

How has EOS imaging performed over the past 5 years?

-15.3%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

EOS imaging does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare EOS imaging's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare EOS imaging's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if EOS imaging has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if EOS imaging has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if EOS imaging improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is EOS imaging's financial position?


Financial Position Analysis

EOS imaging is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

EOS imaging's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

EOS imaging's level of debt (93.3%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has increased over the past 5 years (29.5% vs 93.3% today).


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 2.4x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

EOS imaging has sufficient cash runway for 1.6 years based on current free cash flow.

EOS imaging has sufficient cash runway for 2.4 years if free cash flow continues to grow at historical rates of 17% each year.


Next Steps

Dividend

What is EOS imaging's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate EOS imaging's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate EOS imaging's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as EOS imaging has not reported any payouts.

Unable to verify if EOS imaging's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as EOS imaging has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of EOS imaging's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of EOS imaging's salary, the management and board of directors tenure and is there insider trading?

0.8yrs

Average management tenure


CEO

Mike Lobinsky 0

0.7yrs

Tenure

0

Mr. Mike Lobinsky is Chief Executive Officer of EOS imaging SA since January 1, 2019 and serves as its Director. He was President of North America at EOS imaging SA since joining in August 2017 until Decem ...


Management Age and Tenure

0.8yrs

Average Tenure

The average tenure for the EOS imaging management team is less than 2 years, this suggests a new team.


Board Age and Tenure

5.7yrs

Average Tenure

68yo

Average Age

The tenure for the EOS imaging board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Mike Lobinsky

    CEO & Director

    • Tenure: 0.7yrs
  • Eric Maulavé

    Chief Operating Officer

    • Tenure: 1.9yrs
  • Maurice Delplanque

    Vice President of Engineering

    • Tenure: 0yrs
  • Elisabeth Soubelet

    Chief Medical Officer

    • Tenure: 4.1yrs
  • Youcef Imoussaine

    Field Maintenance Director

    • Tenure: 0yrs
  • Valérie Worrall

    Chief Financial Officer

    • Tenure: 0.8yrs
  • Karen Solie

    Vice President Global Marketing

    • Tenure: 0.8yrs

Board Members

  • Marie Meynadier (58yo)

    Director

    • Tenure: 0yrs
    • Compensation: €682.70k
  • Gérard Hascoët (70yo)

    Chairman of the Board

    • Tenure: 4.2yrs
    • Compensation: €65.00k
  • Eric Beard (68yo)

    Independent Director

    • Tenure: 7.3yrs
    • Compensation: €30.00k
  • Marie-Laure Garrigues

    Director

    • Tenure: 7.8yrs
  • Mike Lobinsky

    CEO & Director

    • Tenure: 0.7yrs
  • Antoine Vidal

    Director

    • Tenure: 1.7yrs

Company Information

EOS imaging SA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: EOS imaging SA
  • Ticker: EOSG.F
  • Exchange: OTCPK
  • Founded: 1989
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €34.780m
  • Listing Market Cap: €38.516m
  • Shares outstanding: 26.19m
  • Website: https://www.eos-imaging.com

Number of Employees


Location

  • EOS imaging SA
  • 10 rue Mercœur
  • Paris
  • Ile-de-France
  • 75011
  • France

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EOSIENXTPA (Euronext Paris)YesCommon StockFREURFeb 2012
0QARLSE (London Stock Exchange)YesCommon StockGBEURFeb 2012
EOSIPBATS-CHIXE (BATS 'Chi-X Europe')YesCommon StockGBEURFeb 2012
EOSG.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDFeb 2012

Biography

EOS imaging SA designs, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications. It offers EOS, a low dose imaging system that provides ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/16 00:20
End of Day Share Price2019/08/14 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.